HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cong Wei Selected Research

qiliqiangxin

8/2019Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes via PI3K/AKT/GSK3β Signaling Pathway.
1/2018A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach.
1/2017Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.
1/2013Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cong Wei Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 07/2011
5Fatigue
07/2021 - 04/2011
5Atherosclerosis
01/2021 - 03/2007
5Ischemic Stroke
09/2020 - 12/2012
5Inflammation (Inflammations)
05/2020 - 09/2015
5Myocardial Infarction
08/2019 - 07/2013
4Fibrosis (Cirrhosis)
05/2020 - 01/2016
4Heart Failure
08/2019 - 07/2010
4Hypoxia (Hypoxemia)
01/2019 - 11/2011
3Body Weight (Weight, Body)
01/2022 - 06/2019
3Leukemia
10/2021 - 12/2019
3Alzheimer Disease (Alzheimer's Disease)
10/2017 - 01/2014
3Lung Neoplasms (Lung Cancer)
03/2016 - 03/2015
2Obesity
01/2022 - 06/2019
2Virus Diseases (Viral Diseases)
01/2022 - 08/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 12/2019
2Stroke (Strokes)
09/2020 - 06/2019
2Wounds and Injuries (Trauma)
05/2020 - 02/2008
2Ischemia
01/2020 - 07/2013
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 01/2016
2Neoplasm Metastasis (Metastasis)
03/2019 - 12/2018
2Reperfusion Injury
01/2019 - 01/2016
2Cardiomegaly (Heart Hypertrophy)
01/2016 - 07/2010
2Hypertrophy
01/2016 - 07/2010
2Bradycardia
01/2015 - 01/2014
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2013 - 12/2012
2Lymphadenopathy
02/2013 - 09/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Bites and Stings (Sting)
01/2022
1Hemolysis
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Proteinuria
12/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021
1Cardiac Arrhythmias (Arrythmia)
11/2020
1Infarction (Infarctions)
09/2020
1Brain Ischemia (Cerebral Ischemia)
09/2020
1COVID-19
07/2020
1Necrotizing Enterocolitis
07/2020
1Atrophy
05/2020
1Dyslipidemias (Dyslipidemia)
05/2020
1Non-alcoholic Fatty Liver Disease
06/2019

Drug/Important Bio-Agent (IBA)

13tongxinluoIBA
09/2020 - 03/2007
8Capsules (Microcapsules)IBA
01/2021 - 04/2007
8Proteins (Proteins, Gene)FDA Link
09/2020 - 04/2011
5CytokinesIBA
01/2021 - 08/2015
4qiliqiangxinIBA
08/2019 - 01/2013
4yangzheng xiaojiIBA
01/2019 - 03/2015
3AntioxidantsIBA
06/2019 - 07/2011
3Amyloid (Amyloid Fibrils)IBA
10/2017 - 01/2014
3Messenger RNA (mRNA)IBA
01/2016 - 04/2011
3shensongyangxinIBA
01/2016 - 01/2014
2Epidermal Growth Factor (EGF)IBA
01/2021 - 08/2015
2salicylhydroxamic acid (SHAM)IBA
05/2020 - 01/2018
2oxidized low density lipoproteinIBA
05/2020 - 03/2019
2Small Interfering RNA (siRNA)IBA
01/2020 - 11/2016
2cyclopamineIBA
06/2019 - 03/2015
2Long Noncoding RNAIBA
03/2019 - 12/2018
2RNA (Ribonucleic Acid)IBA
12/2018 - 03/2016
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2017 - 04/2011
2Peptides (Polypeptides)IBA
01/2016 - 01/2014
2AcidsIBA
01/2016 - 01/2014
2Biological ProductsIBA
09/2015 - 03/2015
2PowdersIBA
02/2008 - 03/2007
1Biomarkers (Surrogate Marker)IBA
01/2022
1Carboxymethylcellulose Sodium (Polycell)FDA Link
01/2022
1Virulence Factors (Pathogenicity Factors)IBA
01/2022
1jinlidaIBA
01/2022
1AntigensIBA
01/2022
1NanovaccinesIBA
01/2022
1EstersIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021
1Lenalidomide (CC 5013)FDA Link
10/2021
1HydrogelsIBA
07/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1ruxolitinibIBA
01/2021
1SteroidsIBA
01/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
1Janus KinasesIBA
01/2021
1alpha-latrotoxin receptorIBA
01/2021
1Silver Sulfadiazine (SSD)FDA LinkGeneric
11/2020
1Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
09/2020
1Interleukin-6 (Interleukin 6)IBA
07/2020
1oridoninIBA
05/2020
1Estrogens (Estrogen)FDA Link
05/2020
1polypeptide 1 70kD ribosomal protein S6 kinaseIBA
01/2020
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2020
1CME-Carbodiimide (CMEC)IBA
01/2020
1GW 4869IBA
01/2020
1Chimeric Antigen ReceptorsIBA
12/2019
1EnzymesIBA
06/2019

Therapy/Procedure

12Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2020 - 11/2011
4Therapeutics
12/2019 - 03/2015
2Hematopoietic Stem Cell Transplantation
10/2021 - 01/2021
2Transplantation
01/2021 - 01/2019
2Ligation
08/2019 - 12/2012
2Drug Therapy (Chemotherapy)
11/2016 - 03/2016
2Microbubbles
09/2014 - 05/2014
2Length of Stay
02/2013 - 09/2010
1Radiofrequency Therapy
01/2021